Skip to main content
AVBP logo

AVBP · ArriVent BioPharma, Inc.

Track AVBP — free
$30.95 -0.08 (-0.26%) At close · Sep 4
Market Cap
$1.53B
Shares
49.31M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 22 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1868279 CUSIP 04272N102 13F (30d) 133 filings 133 filers Visit website Investor relations